Susannah Empson, MD

Residency: Harbor-UCLA Medical Center
Medical School: University of California - San Francisco

The use of exogenous steroids in septic shock is a controversial issue with inconsistent data on mortality to date. Several studies examine sepsis treatment. What does the evidence show?
The ADRENAL trial was designed to test the hypothesis that hydrocortisone results in lower mortality than placebo among patients with septic shock. Find out what investigators discovered.
Could balanced crystalloids offer better outcomes than normal saline infusions? The SMART trial tracked mortality, new renal-replacement therapy, and persistent renal dysfunction among critically ill
CHAT NOW
CHAT OFFLINE